"More Innovation, More Affordably" Named A Top Challenge At TEDMED
This article was originally published in The Gray Sheet
Delegates at April's TEDMED conference rallied around the notion that moving innovative products through FDA more quickly is essential to advancing health care.
You may also be interested in...
Last week's TEDMED conference in Washington, D.C., touted as a gathering of visionaries imagining the future of health and medicine, welcomed U.S. Chief Technology Officer Todd Park and a host of other medtech policymakers and entrepreneurs.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.